07 Jan 2001

Tavegil® (Tavegil® Sirup) - Deutschland

Updated: 07 Jan 2001


Allergien, Pruritus. Parenterale Anw.: Akute Allergien, Adjuvans bei anaphylaktischem Schock und Quincke-Ödem, Prophylaxe von Kontrastmittelallergien und histaminbedingter Komplikationen in d. Anästhesie in Komb. mit einem H2-Rezeptorantagonisten sowie zur Prophylaxe allg. Nebenw. in der Magenfunktionsdiagnostik (Histaminprobe).

Tavegil® Description, Presentation and Dosage

Tavegil® Description

Tavegil® Drug Class Description


Tavegil® Drug Description

10 ml enth.: Clemastinhydrogenfumarat 0,67 mg (entspr. 0,5 mg Base).

Tavegil® Generic Name

Tavegil® Sirup

Tavegil® Presentation

Tavegil® Presentation


Tavegil® Manufacturer

Novartis Consumer Health

Related Learning Zones

CLL Knowledge Centre and CME

CLL Knowledge Centre and CME

The Chronic Lymphocytic Leukaemia (CLL) Knowledge Centre contains useful information arranged within four main sections: ‘Disease Awareness’, ‘Events’, ‘Resources’, and 'CME'. Healthcare professionals will find information on pathophysiology, signs and symptoms of CLL, diagnosis, prognosis, treatment and management options, an upcoming events calendar and an external links listing,

The CME activity ‘Treatment Optimisation in Chronic Lymphocytic Leukaemia’ has been EACCME-accredited and awarded 1 CME credit. Test your knowledge by answering quiz questions based on patient case study scenarios.

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Tavegil® Dosage

Tavegil® Adult Dosage

Parabene E 214 6 mg, E 216 4 mg, Sorbitol 3,5 g, Kaliumdihydrogenphosphat, Natriummonohydrogenphosphat, Saccharin-Natrium, Propylenglycol, Aromastoffe.

Tavegil® Child Dosage

Tavegil® Tabletten
Zus.: 1 Tbl. enth.: Clemastinhydrogenfumarat 1,34 mg (entspr. 1 mg Base).
Weit. Bestandteile: Magnesiumstearat, Povidon, Talkum, Lactose.

Tavegil® Injektionslösung i.v., i.m.
Zus.: 1 Amp. (5 ml) enth.: Clemastinhydrogenfumarat 2,68 mg (entspr. 2 mg Base).
Weit. Bestandteile: Ethanol 140 mg, Sorbitol 90 mg, Natriumcitrat, Natriumchlorid, Propylenglycol, Wasser.

Tavegil® Elderly Dosage

10 ml entspr. 0,29 BE.

Tavegil® Precautions, Reactions and Contraindications

Tavegil® Special Precautions

Tavegil® Special Precautions

A 104, Z 3

Tavegil® Adverse Reactions

Tavegil® Adverse Reactions

Strenge Ind.-Stellung Gr 1 .

Related Drugs - Ear, Nose and Throat

Back to top